Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

por Huillard, O, Mir, O, Peyromaure, M, Tlemsani, C, Giroux, J, Boudou-Rouquette, P, Ropert, S, Delongchamps, N Barry, Zerbib, M, Goldwasser, F
Publicado 2013

Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)

por Moreau-Bachelard, C., Campion, L., Toulmonde, M., Le Cesne, A., Brahmi, M., Italiano, A., Mir, O., Piperno-Neumann, S., Laurence, V., Firmin, N., Penel, N., Duffaud, F., Chevreau, C., Bertucci, F., Narciso, B., Dubray-Longeras, P., Delcambre, C., Saada-Bouzid, E., Boudou-Rouquette, P., Soulie, P., Perrin, C., Blay, J.Y., Bompas, E.
Publicado 2022